ziprasidone has been researched along with Acute Disease in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.26) | 18.2507 |
| 2000's | 28 (73.68) | 29.6817 |
| 2010's | 7 (18.42) | 24.3611 |
| 2020's | 1 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S | 1 |
| Deng, H; Gao, C; Karayal, ON; Li, K; Pan, S; Shi, J; Shu, L; Tang, H; Vanderburg, D; Wang, G; Wang, X; Xie, S; Xu, X; Zhang, H; Zhao, J | 1 |
| Buhl, D; Lamkin, S | 1 |
| Díaz-Marsá, M; Rico-Villademoros, F; Sánchez, S | 1 |
| Citrome, L; Glue, P; Karayal, ON; Yang, R | 1 |
| Loebel, A; Lombardo, I; Mandel, FS; Stahl, S | 1 |
| Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Sitskoorn, MM; van Veelen, NM; Verkes, RJ | 1 |
| Chappell, PB; Gurtovaya, O; Ice, KS; Kasuba, B; Sachs, GS; Schwartz, JH; Vanderburg, DG | 1 |
| Cañas, F; Correll, CU; Fagiolini, A; Larmo, I; Levy, P; Montes, JM; Papageorgiou, G; Rossi, A; Zink, M | 1 |
| Filkowski, MM; Ghaemi, SN; Gilmer, W; Holtzman, NS; Loebel, A; Logvinenko, T; Masand, P; Mulligan, M; Pae, CU; Patkar, A; Pirok, E; Thommi, SB; Vöhringer, PA; Whitham, EA; Ziffra, M | 1 |
| Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E | 1 |
| Giller, E; Ice, K; Keck, PE; Potkin, S; Versiani, M; West, SA | 1 |
| Kane, JM | 1 |
| Brook, S | 1 |
| Dew, RE; Hughes, D | 1 |
| Alvarez, E; Barrachina, J; Oller, S; Pascual, JC; Pérez, V; Soler, J | 1 |
| Minov, C | 1 |
| Ehret, J; Hazaray, E; McDougle, CJ; Petti, TA; Posey, DJ | 1 |
| Benattia, I; Brook, S; Romano, SJ; Siu, CO; Walden, J | 1 |
| Johnson, CE; Mason, MN; Piasecki, M | 1 |
| Cleveland, NJ; Dewitt, CD; Heard, K | 1 |
| Goikolea, JM; Vieta, E | 1 |
| English, P; Ice, K; Keck, PE; Potkin, SG; Segal, S | 1 |
| Adler, CM; Strakowski, SM; Weinstein, SK | 1 |
| Barak, Y; Baruch, Y; Mazeh, D; Plopski, I | 1 |
| Khan, SS; Mican, LM | 1 |
| Mellacheruvu, S; Norton, JW; Schweinfurth, J | 1 |
| Ice, K; Loebel, A; Lombardo, I; Warrington, L | 1 |
| Chua, SE; Chung, AK | 1 |
| Loebel, A; Siu, C; Warrington, L; Yang, R; Zimbroff, D | 1 |
| Duggal, HS; Singh, I | 1 |
| Cutler, AJ; Hamilton, J; Kalali, AH; Weiden, PJ; Wolfgang, CD | 1 |
| Agid, O; Kapur, S; Loebel, A; Siu, C; Warrington, L | 1 |
| Buffenstein, A; Feighner, J; Ferguson, J; Harrigan, EP; Jaffe, W; Keck, P; Morrissey, MR | 1 |
| Daniel, DG; Harrigan, EP; Lakshminarayanan, M; Potkin, SG; Reeves, KR; Zimbroff, DL | 1 |
| Brook, S; Gunn, KP; Lucey, JV | 1 |
| Cañas, F | 1 |
| Caley, CF; Cooper, CK | 1 |
7 review(s) available for ziprasidone and Acute Disease
| Article | Year |
|---|---|
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes | 2020 |
Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder.
Topics: Acute Disease; Antipsychotic Agents; Bipolar Disorder; Humans; Molecular Structure; Piperazines; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Thiazoles | 2011 |
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles | 2013 |
Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
Topics: Acute Disease; Antipsychotic Agents; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Humans; Injections, Intramuscular; Piperazines; Psychomotor Agitation; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles; Treatment Outcome | 2003 |
Atypical antipsychotics: newer options for mania and maintenance therapy.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Humans; Lithium Carbonate; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2005 |
Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Dopamine D2 Receptor Antagonists; Humans; Piperazines; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Treatment Outcome | 2007 |
Ziprasidone: the fifth atypical antipsychotic.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Headache; Humans; Injections, Intramuscular; Long QT Syndrome; Nausea; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain | 2002 |
17 trial(s) available for ziprasidone and Acute Disease
| Article | Year |
|---|---|
Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; China; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Injections, Intramuscular; Least-Squares Analysis; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Thiazoles; Time Factors; Young Adult | 2013 |
Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.
Topics: Acute Disease; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Administration Schedule; Female; Hospitalization; Humans; In Vitro Techniques; Length of Stay; Piperazines; Prospective Studies; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome | 2009 |
Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Benzodiazepines; Cognition; Cross-Over Studies; Double-Blind Method; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Young Adult | 2010 |
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium; Male; Middle Aged; Piperazines; Serotonin Antagonists; Thiazoles; Treatment Outcome; Triazines; Valproic Acid; Young Adult | 2011 |
A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles; Treatment Outcome | 2012 |
Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Thiazoles; Treatment Outcome | 2003 |
Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Borderline Personality Disorder; Drug Administration Schedule; Emergency Services, Psychiatric; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome | 2004 |
Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study.
Topics: Acute Disease; Administration, Oral; Adult; Affective Disorders, Psychotic; Brief Psychiatric Rating Scale; Demography; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Manifest Anxiety Scale; Piperazines; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Withholding Treatment | 2005 |
Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome | 2005 |
Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.
Topics: Acute Disease; Aged; Aged, 80 and over; Antipsychotic Agents; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Thiazoles | 2006 |
Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study.
Topics: Acute Disease; Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Aripiprazole; Blood Glucose; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Dyspepsia; Electrocardiography; Fasting; Humans; Lipids; Nausea; Piperazines; Prolactin; Quinolones; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Weight Loss | 2007 |
Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Isoxazoles; Male; Middle Aged; Piperazines; Piperidines; Prospective Studies; Schizophrenia; Thiazoles; Treatment Outcome | 2008 |
Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hospitalization; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Thiazoles; Time Factors; Treatment Outcome | 2008 |
Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles | 1998 |
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles | 1999 |
Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Administration Schedule; Female; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychotic Disorders; Severity of Illness Index; Thiazoles; Treatment Outcome | 2000 |
14 other study(ies) available for ziprasidone and Acute Disease
| Article | Year |
|---|---|
Extrapyramidal side effects: could you identify them in the emergency department?
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Dystonia; Emergency Nursing; Emergency Treatment; Female; Humans; Infant; Male; Muscle Rigidity; Nursing Assessment; Parkinson Disease, Secondary; Piperazines; Risk Factors; Risperidone; Syndrome; Thiazoles | 2009 |
Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies.
Topics: Acute Disease; Adult; Affect; Aged; Bipolar Disorder; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles | 2010 |
Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
Topics: Acute Disease; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Humans; Long-Term Care; Piperazines; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles | 2003 |
Acute dystonic reaction with moderate-dose ziprasidone.
Topics: Acute Disease; Adult; Alcoholism; Antipsychotic Agents; Cocaine-Related Disorders; Dystonic Disorders; Female; Hallucinations; Humans; Piperazines; Risk Factors; Thiazoles; Tongue Diseases; Torticollis; Violence | 2004 |
[Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
Topics: Acute Disease; Aged; Antipsychotic Agents; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Hallucinations; Humans; Long QT Syndrome; Male; Piperazines; Quetiapine Fumarate; Schizophrenia, Paranoid; Thiazoles | 2004 |
Intramuscular ziprasidone for acute agitation in adolescents.
Topics: Acute Disease; Adolescent; Aggression; Child; Humans; Injections, Intramuscular; Male; Piperazines; Psychomotor Agitation; Thiazoles | 2004 |
Ziprasidone-induced acute dystonia.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Dystonia; Humans; Male; Middle Aged; Piperazines; Schizophrenia, Paranoid; Thiazoles | 2005 |
Ziprasidone pretreatment attenuates the lethal effects of cocaine in a mouse model.
Topics: Acute Disease; Animals; Antipsychotic Agents; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Overdose; Injections, Intraperitoneal; Mice; Piperazines; Premedication; Random Allocation; Seizures; Single-Blind Method; Survival Analysis; Thiazoles; Treatment Outcome | 2005 |
Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Male; Piperazines; Thiazoles | 2006 |
A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents.
Topics: Acute Disease; Adolescent; Aggression; Antipsychotic Agents; Benzodiazepines; Child; Ethnicity; Female; Humans; Injections, Intramuscular; Inpatients; Male; Olanzapine; Piperazines; Psychomotor Agitation; Retrospective Studies; Sex Characteristics; Thiazoles; Treatment Outcome | 2006 |
Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Dystonia; Humans; Laryngeal Diseases; Male; Middle Aged; Piperazines; Thiazoles | 2007 |
Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone.
Topics: Acute Disease; Antipsychotic Agents; Depressive Disorder, Major; Drug Monitoring; Electroconvulsive Therapy; Humans; Male; Middle Aged; Piperazines; Receptors, Serotonin, 5-HT2; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Urinary Catheterization; Urinary Retention | 2007 |
Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.
Topics: Acute Disease; Antipsychotic Agents; Brief Psychiatric Rating Scale; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Psychoses, Substance-Induced; Thiazoles | 2008 |
Sustaining short-term gains for future progress.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Thiazoles | 2001 |